Management of hormone refractory prostate cancer : Current standards and future prospects. EditorialOH, W. K; KANTOFF, P. W; RAGHAVAN, D et al.The Journal of urology. 1998, Vol 160, Num 4, pp 1220-1231, issn 0022-5347Article

Prognostic indicators in hormone refractory prostate cancer : Hormone refractory prostate cancerGEORGE, D. J; KANTOFF, P. W.Urologic clinics of North America. 1999, Vol 26, Num 2, issn 0094-0143, viii,303-310 [9 p.]Article

Gallium-67-citrate imaging in extragonadal and gonadal seminomas : relationship to radiologic findingsUCHIYAMA, M; KAPLAN, W. D et al.JNM. The journal of nuclear medicine (1990). 1994, Vol 35, Num 10, pp 1624-1630Article

Potential applications of gene therapyKOHN, D. B; KANTOFF, P. W.Transfusion (Philadelphia, PA). 1989, Vol 29, Num 9, pp 812-820, issn 0041-1132, 9 p.Article

Treatment of locally advanced prostate cancer : Is chemotherapy the next step?OH, W. K; KANTOFF, P. W.Journal of clinical oncology. 1999, Vol 17, Num 11, pp 3664-3675, issn 0732-183XArticle

Chemotherapy for muscle-infiltrating bladder cancerSCHER, H. I; KANTOFF, P. W.Hematology/oncology clinics of North America. 1992, Vol 6, Num 1, pp 169-178, issn 0889-8588Article

Chemotherapy for metastatic bladder cancerKANTOFF, P. W; SCHER, H. I.Hematology/oncology clinics of North America. 1992, Vol 6, Num 1, pp 195-203, issn 0889-8588Article

Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer ?RICHIE, J. P; KANTOFF, P. W.Journal of clinical oncology. 1991, Vol 9, Num 8, pp 1393-1396, issn 0732-183XArticle

The prostate specific antigen : its use as a tumor marker for prostate cancerKANTOFF, P. W; TALCOTT, J. A.Hematology/oncology clinics of North America. 1994, Vol 8, Num 3, pp 555-572, issn 0889-8588Article

Regulation of S100P expression by androgenAVERBOUKH, L; LIANG, P; KANTOFF, P. W et al.The Prostate. 1996, Vol 29, Num 6, pp 350-355, issn 0270-4137Article

Prospects for gene therapy for immunodeficiency diseasesKANTOFF, P. W; FREEMAN, S. M; ANDERSON, W. F et al.Annual review of immunology. 1988, Vol 6, pp 581-594, issn 0732-0582, 14 p.Article

14-day continuous infusion of mitoxantrone in hormone-refractory metastatic adenocarcinoma of the prostateKANTOFF, P. W; BLOCK, C; LETVAK, L et al.American journal of clinical oncology. 1993, Vol 16, Num 6, pp 489-491, issn 0277-3732Article

Histologic demonstration of intradermal spirochetes in a patient with lyme diseaseKANTOFF, P. W; SHUPACK, J. L; GREENE, J. B et al.The American journal of the medical sciences. 1984, Vol 287, Num 2, pp 40-42, issn 0002-9629Article

Neoadjuvant and adjuvant chemotherapy for invasive bladder cancerSMITH, M. R; KANTOFF, P. W.Seminars in oncology. 1995, Vol 22, Num 6, pp 625-632, issn 0093-7754Article

Cancer and leukemia group B trials for advanced prostate cancerSMALL, E. J; DAWSON, N. A; KANTOFF, P. W et al.Seminars in oncology. 1996, Vol 23, Num 6, pp 28-31, issn 0093-7754, SUP14Conference Paper

Long-term followup of 150 patients with testicular cancer treated at a single institutionKANTOFF, P. W; KALISH, L. A; MCDOWELL-BRYANT, B et al.The Journal of urology. 1992, Vol 147, Num 1, pp 82-88, issn 0022-5347Article

Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancerOH, W. K; KANTOFF, P. W.Seminars in oncology. 1999, Vol 26, Num 5, pp 49-54, issn 0093-7754, SUP17Article

A prognostic score for hormone-refractory prostate cancer : Analysis of two cancer and leukemia group B studiesVOLLMER, R. T; KANTOFF, P. W; DAWSON, N. A et al.Clinical cancer research. 1999, Vol 5, Num 4, pp 831-837, issn 1078-0432Article

Meningeal carcinomatosis from transitional cell carcinoma of the bladderENG, C; CUNNINGHAM, D; QUADE, B. J et al.Cancer. 1993, Vol 72, Num 2, pp 553-557, issn 0008-543XArticle

In utero gene transfer and expression: a sheep transplantation modelKANTOFF, P. W; FLAKE, A. W; EGLITIS, M. A et al.Blood. 1989, Vol 73, Num 4, pp 1066-1073, issn 0006-4971Article

Effect of internal viral sequences on the utility of retroviral vectorsARMENTANO, D; SHEAU-FUNG YU; KANTOFF, P. W et al.Journal of virology. 1987, Vol 61, Num 5, pp 1647-1650, issn 0022-538XArticle

Gene therapy: efforts at developing large animal models for autologous bone marrow transplant and gene transfer with retroviral vectorsEGLITIS, M. A; KANTOFF, P. W; GILBOA, E et al.Ciba Foundation symposium. 1987, Num 130, pp 229-246, issn 0300-5208Conference Paper

Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerMICHAELSON, M. D; BELLMUNT, J; NIETO, A et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1234-1240, issn 0923-7534, 7 p.Article

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients : A prospective multiinstitutional outcomes studyBEARD, C. J; PROPERT, K. J; RIEKER, P. P et al.Journal of clinical oncology. 1997, Vol 15, Num 1, pp 223-229, issn 0732-183XArticle

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors : a randomized trialBAJORIN, D. F; NICHOLS, C. R; SCHMOLL, H.-J et al.Journal of clinical oncology. 1995, Vol 13, Num 1, pp 79-86, issn 0732-183XArticle